Reports for ARALEZ PHARMACEUTICALS CANADA INC
Company Name
ARALEZ PHARMACEUTICALS CANADA INC
Totals |
||
Shortage reports |
5 |
|
| Actual shortage: | 0 (0%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 0 (0%) | |
| Resolved: | 5 (100%) | |
Discontinuation Reports |
0 |
|
| To be discontinued: | 0 | |
| Discontinued: | 0 | |
| Reversed: | 0 | |
Late reports |
0 (0%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| FIORINAL-C 1/2 | 330MG 40MG 30MG 50MG | CAPSULE | Resolved | 2020-06-16 | 2020-10-01 | 117997 |
| FIORINAL-C 1/4 | 330MG 50MG 15MG 40MG | CAPSULE | Resolved | 2020-01-09 | 2020-10-22 | 102895 |
| MOVIPREP | 4.7G 5.9G 1.015G 2.691G 7.5G 100G | POWDER FOR SOLUTION | Resolved | 2022-08-10 | 2022-10-01 | 166431 |
| PEGALAX | 100% | POWDER FOR SOLUTION | Resolved | 2022-02-18 | 2022-03-10 | 155275 |
| PEGALAX | 100% | POWDER FOR SOLUTION | Resolved | 2022-08-01 | 2022-09-26 | 165841 |
Showing 1 to 5 of 5
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0